What is disclosed is a method for encoding liquid ink with a biomarker which can be traced back to a specific inkjet printer. In one embodiment, an aqueous solution containing a biomarker is combined with a volume of liquid ink. The biomarker comprises a nucleic acid. An ordering of nucleobases forming that nucleic acid has a code sequence. In one embodiment hereof, the nucleic acid is constructed using a code sequence which contains, at least in part, the device specific serial number of the inkjet printer. The encoded liquid ink is added to an inkjet printer and the code sequence encoded in that ink is associated with that particular inkjet printer. The inkjet printer is then used to deposit the encoded ink onto a media substrate. In other embodiments, a fluorescent marker is also added with the volume of liquid ink such that the ink fluoresces under an ultraviolet light.

Patent
   10047235
Priority
Dec 08 2015
Filed
Dec 08 2015
Issued
Aug 14 2018
Expiry
Sep 22 2036
Extension
289 days
Assg.orig
Entity
Large
11
20
currently ok
11. A liquid ink for an inkjet printer comprising:
a volume of liquid ink; and
an aqueous solution containing a nucleic acid, said nucleic acid having been replicated to contain ordered nucleobases, an ordering of said nucleobases comprising a code sequence associated with a specific inkjet printer, said association being any of: a sticker with said code sequence placed on to said specific inkjet printer, and a serial number of said specific inkjet printer, said aqueous solution being mixed with said volume of liquid ink, said mixing being any of: replacing an amount of said liquid ink with said aqueous solution, and adding said aqueous solution to said liquid ink, a sequencer being able to obtain said ordering of said nucleobases from said mixed volume of liquid ink thereby enabling a media substrate printed with said mixed volume of liquid ink to be traced back to said specific inkjet printer.
1. A method for tracing a printed media back to a specific inkjet printer, the method comprising:
replicating a nucleic acid containing ordered nucleobases, an ordering of said nucleobases comprising a code sequence associated with a specific inkjet printer;
mixing, with a volume of liquid ink, an aqueous solution containing said nucleic acid sequence with a volume of liquid ink, said mixing being any of: replacing an amount of said liquid ink with said aqueous solution, and adding said aqueous solution to said liquid ink;
adding said mixed volume of liquid ink to said specific inkjet printer;
depositing, by said specific inkjet printer, said added mixed volume of liquid ink on to a media substrate to generate a printed media;
using a sequencer to decode said ordered nucleobases mixed with said volume of liquid ink deposited on said printed media to obtain said code sequence; and
using said obtained code sequence to identify said specific inkjet printer used to generate said printed media.
2. The method of claim 1, wherein mixing comprises replacing a volume of liquid ink with a similar volume of aqueous solution such that a total concentration of water in said liquid ink remains substantially unchanged.
3. The method of claim 1, wherein said given code sequence is alphabetic.
4. The method of claim 1, wherein said nucleobases are formed between any two of: Adenine (A), Cytosine (C), Guanine (G), Thymine (T), and Uracil (U).
5. The method of claim 1, wherein at least one nucleobase is an unnatural base pair (UBP).
6. The method of claim 1, wherein at least one nucleobase is a derivative of a heterocyclic compound containing a metal ion.
7. The method of claim 1, further comprising adding a fluorescent marker such that said liquid ink fluoresces under an ultraviolet light.
8. The method of claim 1, wherein said given code sequence is alphanumeric.
9. The method of claim 1, wherein said given code sequence is binary.
10. The method of claim 1, wherein said given code sequence is symbolic.
12. The liquid ink of claim 11, wherein said aqueous solution replaces a volume of liquid ink with a similar volume of aqueous solution such that a total concentration of water in said liquid ink remains substantially unchanged.
13. The liquid ink of claim 11, wherein said code sequence is alphabetic.
14. The liquid ink of claim 11, wherein said nucleobases are formed between any two of: Adenine (A), Cytosine (C), Guanine (G), Thymine (T), and Uracil (U).
15. The liquid ink of claim 11, wherein at least one nucleobase is an unnatural base pair (UBP).
16. The liquid ink of claim 11, further comprising adding a fluorescent marker such that said liquid ink fluoresces under an ultraviolet light.
17. The liquid ink of claim 11, wherein at least one nucleobase is a derivative of a heterocyclic compound containing a metal ion.
18. The liquid ink of claim 11, wherein said given code sequence is alphanumeric.
19. The liquid ink of claim 11, wherein said given code sequence is binary.
20. The liquid ink of claim 11, wherein said given code sequence is symbolic.

The present invention is directed to methods for encoding liquid ink with a biomarker which can be traced back to a particular inkjet printer.

For security reasons, it is desirable to be able to authenticate a first generation document and further to be able to trace an original document back to a particular printer.

What is disclosed is a method for encoding liquid ink with a biomarker which can be traced back to a specific inkjet printer. In one embodiment, an aqueous solution containing a biomarker is combined with a volume of liquid ink. The biomarker comprises a nucleic acid. An ordering of nucleobases forming that nucleic acid has a code sequence. In one embodiment, the nucleic acid is constructed using a code sequence which contains, at least in part, the serial number of the inkjet printer. The encoded liquid ink is added to an inkjet printer and the code sequence encoded in that ink is associated with that particular inkjet printer. The inkjet printer is then used to deposit the encoded ink onto a media substrate. In other embodiments, a fluorescent marker is also added with the liquid ink such that the ink fluoresces under an ultraviolet light thereby providing a visual indication that the printed media has been printed with encoded liquid ink. Features and advantages of the present invention will become apparent from the following detailed description and accompanying drawings.

The foregoing and other features and advantages of the subject matter disclosed herein will be made apparent from the following detailed description taken in conjunction with the accompanying drawings.

FIG. 1 shows an example code sequence obtained as a result of having decoded a nucleic acid using a sequencer.

FIG. 2 is a flow diagram of one example embodiment of the present method for encoding liquid ink with a biomarker which can be traced back to a particular inkjet printer.

What is disclosed is a method for encoding liquid ink with a biomarker which can be traced back to a particular inkjet printer.

An “aqueous solution” means a solution in which water (H2O) is the solvent. The aqueous solution hereof contains a nucleic acid.

A “nucleic acid sequence” or simply “nucleic acid” is a macromolecule produced by biosynthesis, gene sequencing, or enzymatic synthesis. Although nucleic acids are naturally occurring in biological cellular structures, they can be designed to have a given sequence over a given length. Moreover, the sequence can be repeated over and over again in the nucleic acid. A given sequence can be replicated using, for example, oligonucleotide primers and a polymerase. Other methods for replicating a given nucleic acid sequence are well known in the genetic engineering arts. A nucleic acid sequence is made from building blocks of nucleotides.

“Nucleotides” are molecules comprising at least a nucleobase (also called a nitrogenous base), a five-carbon sugar (either 2-deoxyribose in the case of DNA or ribose in the case of RNA), and a phosphate group. Without the phosphate group, the nucleobase and sugar combination is called a nucleoside. Nucleobases are referred to as base pairs. At least one nucleobase is a derivative of a heterocyclic compound containing a metal ion.

“Base pairs” are either natural or unnatural. Natural base pairs are formed with any two of: Adenine (A), Cytosine (C), Guanine (G), or Uracil (U). Uracil and Thymine are identical except that Uracil lacks a 5′ methyl group. An unnatural base pair (UBP), as used herein, is one which is not naturally occurring. The ordering of the base pairs forms a code sequence.

A “code sequence”, or simply “sequence”, visually explains the ordering of the base pairs of a given nucleic acid which may or may not be unique. FIG. 1 shows an example sequence at 100 obtained as a result of having decoded a nucleic acid using a process of electrophoresis. The sequence can be alphabetic, numeric, alphanumeric, or symbolic. The sequence can be any length. The sequence can be given as a binary sequence of 1's and 0's, or a series of geometric symbols. The coding sequence will depend on the methodology employed to decode the nucleic acid. In DNA sequences comprising a double-stranded pattern, by convention, the top strand is written from the 5′ end to the 3′ end and the bottom strand is written from the 3′ to the 5′. Nucleic acids can be decoded using a gene sequencer. In one embodiment hereof, the nucleic acid is constructed using a code sequence which contains, at least in part, the serial number of the inkjet printer.

A “gene sequencer” or simply “sequencer” is a highly sophisticated scientific instrument used to decode the ordering of the base pairs. The decoded ordering is reported as a string of numbers, characters, symbols, etc., depending on the design of the instrument. Some sequencers are considered optical instruments as they analyze light signals originating from fluorochromes attached to the nucleotides. Sequencers are commercially available in various streams of commerce by different vendors such as, for example, Hoffmann LaRoche, Illumina, Thermo Fisher Scientific, and Pacific Biosciences of California.

“Mixing” means combining and may involve stirring or shaking to achieve a desired uniformity. In one embodiment, the mixing involves replacing a volume of liquid ink with a volume of aqueous solution such that a total concentration of water in the volume of liquid ink remains substantially unchanged. In another embodiment, mixing involves adding an amount of aqueous solution to the liquid ink such that it does not exceed 1% by volume of liquid ink. A fluorescent marker may be added either directly to the liquid ink or to the aqueous solution such that the ink printed on the media substrate fluoresces under ultraviolet light.

“Associating” a code sequence with an inkjet printer means to use the encoded volume of liquid ink in a manner such that, upon decoding, the printed media can effectively be traced to a particular printer. In one example, the associating comprises placing a sticker with the ink's code sequence onto the inkjet printer. This list is exemplary and is not to be view as limiting. Other forms of “mixing” as well as other forms of “associating” are intended to fall within the scope of the appended claims.

Flow Diagram of One Embodiment

Reference is now being made to FIG. 2 which is a flow diagram of one embodiment of the present method for encoding liquid ink with a biomarker which can be traced to a particular inkjet printer. Flow processing begins at step 200 and immediately proceeds to step 202.

At step 202, mix an aqueous solution containing a nucleic acid with a volume of liquid ink, an ordering of pairs of nucleobases forming the nucleic acid has a code sequence. One example of a code sequence is shown in FIG. 1. In one embodiment hereof, the nucleic acid is constructed using a code sequence which contains, at least in part, the serial number of the inkjet printer.

At step 204, add the mixed volume of liquid ink to an inkjet printer. This can be effectuated by, for example, installing the inkjet cartridge containing the encoded liquid ink into the inkjet printer.

At step 206, associate the code sequence with the inkjet printer (of step 204). This can be done by, for example, attaching a sticker containing the code sequence onto the inkjet printer, or by saving the code sequence to a software or hardware file or folder which, in turn, is associated with the serial number of the inkjet printer.

At step 208, use the inkjet printer to deposit the encoded ink onto a media substrate such as, for example, a sheet of xerographic paper.

At step 210, a determination is made whether to mix another aqueous solution to a volume of liquid ink. If so, then flow processing continues withrespect to step 202 wherein another aqueous solution is mixed with the same or a different volume of liquid ink. Flow processing repeats in a similar manner until no more aqueous solutions are desired to be mixed with another volume of liquid ink. Thereafter, in this embodiment, flow processing stops.

It should be understood that the flow diagrams depicted herein are illustrative. One or more of the operations illustrated in the flow diagrams may be performed in a differing order. Other operations may be added, modified, enhanced, or consolidated. Variations thereof are intended to fall within the scope of the appended claims.

One or more aspects of the teachings herein are intended to be incorporated in an article of manufacture which may be shipped, sold, leased, or otherwise provided separately either alone or as part of a product suite or a service. The above-disclosed and other features, functions, or alternatives thereof, may be desirably combined into other different systems or applications. Presently unforeseen or unanticipated alternatives, modifications, variations, or improvements may become apparent and/or subsequently made by those skilled in this art which are also intended to be encompassed by the following claims.

Wilsher, Michael John, Lewis, Jeremy Brook

Patent Priority Assignee Title
10650312, Nov 16 2016 CATALOG TECHNOLOGIES, INC Nucleic acid-based data storage
11227219, May 16 2018 CATALOG TECHNOLOGIES, INC. Compositions and methods for nucleic acid-based data storage
11286479, Mar 16 2018 CATALOG TECHNOLOGIES, INC Chemical methods for nucleic acid-based data storage
11306353, May 11 2020 CATALOG TECHNOLOGIES, INC Programs and functions in DNA-based data storage
11379729, Nov 16 2016 CATALOG TECHNOLOGIES, INC. Nucleic acid-based data storage
11535842, Oct 11 2019 CATALOG TECHNOLOGIES, INC Nucleic acid security and authentication
11610651, May 09 2019 CATALOG TECHNOLOGIES, INC.; CATALOG TECHNOLOGIES, INC Data structures and operations for searching, computing, and indexing in DNA-based data storage
11763169, Nov 16 2016 CATALOG TECHNOLOGIES, INC Systems for nucleic acid-based data storage
ER5446,
ER5904,
ER9180,
Patent Priority Assignee Title
5135569, Aug 24 1990 W R GRACE & CO -CONN , A CORP OF CT Ink composition containing fluorescent component and method of tagging articles therewith
5139812, Jul 07 1989 Bioprobe Systems Method and apparatus for high security crypto-marking for protecting valuable objects
5388158, Nov 20 1992 Pitney Bowes Inc. Secure document and method and apparatus for producing and authenticating same
5451505, May 22 1989 Roche Molecular Systems, Inc Methods for tagging and tracing materials with nucleic acids
6030657, Nov 01 1994 POLESTAR, LTD Labeling technique for countering product diversion and product counterfeiting
6582138, Aug 21 2000 Xerox Corporation Authenticated sheet material
6616964, Mar 31 1999 Norbert, Hampp Method and preparation for the photochromic marking and/or for securing the authenticity of objects
6706314, Mar 15 2001 Butland Trust Organization Method of labelling an object
7314216, Apr 19 2005 Xerox Corporation Method for making a unique code onto a paper edge
7982918, Nov 01 2007 Xerox Corporation Image annotation using barcodes
8596526, Jan 26 2008 Smartwater Research Limited Methods of in-field analysis
20050045063,
20070172429,
20090042191,
20100184154,
20130221277,
20150307728,
EP938416,
JP2006169341,
WO8706383,
////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 02 2015WILSHER, MICHAEL JOHNXerox CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0442320532 pdf
Dec 02 2015LEWIS, JEREMY BROOKXerox CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0442320532 pdf
Dec 08 2015Xerox Corporation(assignment on the face of the patent)
Nov 07 2022Xerox CorporationCITIBANK, N A , AS AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0627400214 pdf
May 17 2023CITIBANK, N A , AS AGENTXerox CorporationRELEASE OF SECURITY INTEREST IN PATENTS AT R F 062740 02140636940122 pdf
Jun 21 2023Xerox CorporationCITIBANK, N A , AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0647600389 pdf
Nov 17 2023Xerox CorporationJEFFERIES FINANCE LLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0656280019 pdf
Feb 06 2024Xerox CorporationCITIBANK, N A , AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0667410001 pdf
Date Maintenance Fee Events
Jan 28 2022M1551: Payment of Maintenance Fee, 4th Year, Large Entity.


Date Maintenance Schedule
Aug 14 20214 years fee payment window open
Feb 14 20226 months grace period start (w surcharge)
Aug 14 2022patent expiry (for year 4)
Aug 14 20242 years to revive unintentionally abandoned end. (for year 4)
Aug 14 20258 years fee payment window open
Feb 14 20266 months grace period start (w surcharge)
Aug 14 2026patent expiry (for year 8)
Aug 14 20282 years to revive unintentionally abandoned end. (for year 8)
Aug 14 202912 years fee payment window open
Feb 14 20306 months grace period start (w surcharge)
Aug 14 2030patent expiry (for year 12)
Aug 14 20322 years to revive unintentionally abandoned end. (for year 12)